Stock Watch: Trouble In The Pharmaceutical Value Chain
Fundamental Trends Loom Over The Sector’s Picks And Shovels
The biotechnology and pharmaceutical sectors outsource much of their drug discovery and clinical development efforts to contract organizations. Investors’ reduced appetite for biotech is now impacting those contractors.
